chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia, Vaccination site erythema, Vaccination site nodule
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site nodule (hard knot in it as big as a 50 cent piece), nausea, vaccination site swelling (injection site arm is swollen), headache and pyrexia (mild temperature) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 19, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced vaccination site swelling (injection site arm is swollen). On an unknown date, patient experienced  vaccination site nodule (hard knot in it as big as a 50 cent piece), nausea, headache, pyrexia (mild temperature), vaccination site erythema (red) and vaccination site pain (sore). At the time of the report, vaccination site nodule (hard knot in it as big as a 50 cent piece), nausea, vaccination site swelling (injection site arm is swollen), headache, pyrexia (mild temperature), vaccination site erythema (red) and vaccination site pain (sore) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant product use or treatment information provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site nodule (hard knot in it as big as a 50 cent piece), nausea, vaccination site swelling (injection site arm is swollen), headache and pyrexia (mild temperature) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006B21A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Mar 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 19, 2021, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced vaccination site swelling (injection site arm is swollen). On an unknown date, patient experienced  vaccination site nodule (hard knot in it as big as a 50 cent piece), nausea, headache, pyrexia (mild temperature), vaccination site erythema (red) and vaccination site pain (sore). At the time of the report, vaccination site nodule (hard knot in it as big as a 50 cent piece), nausea, vaccination site swelling (injection site arm is swollen), headache, pyrexia (mild temperature), vaccination site erythema (red) and vaccination site pain (sore) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant product use or treatment information provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant and vaccinated; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant and vaccinated) in a 30-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CETIRIZINE HYDROCHLORIDE (CETRAK) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 28-Oct-2020 and the estimated date of delivery was 28-Jul-2021. On 22-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant and vaccinated). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant and vaccinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Injection site erythema, Injection site pain, Injection site pruritus, Nausea
Clinical narrative: At night heart rate went up a little bit; Tenderness at the injection site; Nausea; Soreness in the arm at the injection site; Itching at the injection site; Red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (At night heart rate went up a little bit), INJECTION SITE PAIN (Tenderness at the injection site), NAUSEA (Nausea), INJECTION SITE PAIN (Soreness in the arm at the injection site) and INJECTION SITE PRURITUS (Itching at the injection site) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEART RATE INCREASED (At night heart rate went up a little bit), INJECTION SITE PAIN (Tenderness at the injection site), NAUSEA (Nausea), INJECTION SITE PAIN (Soreness in the arm at the injection site), INJECTION SITE PRURITUS (Itching at the injection site) and INJECTION SITE ERYTHEMA (Red spot at the injection site). At the time of the report, HEART RATE INCREASED (At night heart rate went up a little bit), INJECTION SITE PAIN (Tenderness at the injection site), NAUSEA (Nausea), INJECTION SITE PAIN (Soreness in the arm at the injection site), INJECTION SITE PRURITUS (Itching at the injection site) and INJECTION SITE ERYTHEMA (Red spot at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, Back pain, Diarrhoea, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), BACK PAIN (back pain), ANOSMIA (loss of smell) and PAIN IN EXTREMITY (arm pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included EMTRICITABINE, TENOFOVIR DISOPROXIL FUMARATE (TRUVADA) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 21-Mar-2021, the patient experienced DIARRHOEA (diarrhea), BACK PAIN (back pain) and ANOSMIA (loss of smell). The patient was treated with IBUPROFEN at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 21-Mar-2021, PAIN IN EXTREMITY (arm pain) had resolved. At the time of the report, DIARRHOEA (diarrhea), BACK PAIN (back pain) and ANOSMIA (loss of smell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Insomnia
Clinical narrative: Cant sleep at night; Dizziness; headache; weak and tired; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Cant sleep at night), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (weak and tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Cant sleep at night), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (weak and tired). At the time of the report, INSOMNIA (Cant sleep at night), DIZZINESS (Dizziness) and FATIGUE (weak and tired) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       relevant concomitant products usage were not reported by the reporter. Treatment details not included.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: Joint pain; Tired; Redness about 50 cents piece round; lump; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness about 50 cents piece round), VACCINATION SITE PAIN (Soreness), VACCINATION SITE MASS (lump), ARTHRALGIA (Joint pain) and FATIGUE (Tired) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concomitant products included NAPROXEN SODIUM (ALEVE) for Knee pain.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness). On 21-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness about 50 cents piece round) and VACCINATION SITE MASS (lump). On an unknown date, the patient experienced ARTHRALGIA (Joint pain) and FATIGUE (Tired). At the time of the report, VACCINATION SITE ERYTHEMA (Redness about 50 cents piece round), VACCINATION SITE PAIN (Soreness), VACCINATION SITE MASS (lump), ARTHRALGIA (Joint pain) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment included
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity
Clinical narrative: Crumps on her right ankle and foot; Arm was really sore; This spontaneous case was reported by a physician and describes the occurrence of MUSCLE SPASMS (Crumps on her right ankle and foot) and PAIN IN EXTREMITY (Arm was really sore) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included Open heart surgery (Open heart surgery at 6 y/o for a congenital problem.) and Knee replacement (2 knee replacements.). Concomitant products included OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), DILTIAZEM HYDROCHLORIDE (CARDIZEM [DILTIAZEM HYDROCHLORIDE]), VITAMINS NOS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced MUSCLE SPASMS (Crumps on her right ankle and foot) and PAIN IN EXTREMITY (Arm was really sore). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. On 28-Feb-2021, PAIN IN EXTREMITY (Arm was really sore) had resolved. At the time of the report, MUSCLE SPASMS (Crumps on her right ankle and foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included Stuff for her hair and Half of a 25 mg water pill. Treatment information included creams. Doesn't have blood pressure on left arm because she was born without a subclavian artery.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Headache, Pain in extremity, Pyrexia
Clinical narrative: Alopecia; Painful arm; Chills; FEVER; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Alopecia), PAIN IN EXTREMITY (Painful arm), CHILLS (Chills), PYREXIA (FEVER) and HEADACHE (Headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Alopecia), PAIN IN EXTREMITY (Painful arm), CHILLS (Chills), PYREXIA (FEVER) and HEADACHE (Headache). At the time of the report, ALOPECIA (Alopecia), PAIN IN EXTREMITY (Painful arm), CHILLS (Chills), PYREXIA (FEVER) and HEADACHE (Headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications were reported. No treatment for the events was provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: a little headache; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (a little headache) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 015M20A) for COVID-19 vaccination.     The patient's past medical history included Cancer.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2021, the patient experienced HEADACHE (a little headache). On 19-Jan-2021, HEADACHE (a little headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. treatment information was not reported.   This case was linked to MOD-2021-046018 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Grip strength, Injection site erythema, Injection site pain, Injection site pruritus, Injection site warmth
Clinical narrative: Hard to pick up things; warm at the injection site; itchy at the injection site; muscle aches on the whole side of the arm; sore at the injection site; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of GRIP STRENGTH (Hard to pick up things), INJECTION SITE WARMTH (warm at the injection site), INJECTION SITE PRURITUS (itchy at the injection site), MYALGIA (muscle aches on the whole side of the arm) and INJECTION SITE PAIN (sore at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced GRIP STRENGTH (Hard to pick up things), INJECTION SITE WARMTH (warm at the injection site), INJECTION SITE PRURITUS (itchy at the injection site), MYALGIA (muscle aches on the whole side of the arm), INJECTION SITE PAIN (sore at the injection site) and INJECTION SITE ERYTHEMA (red at the injection site). At the time of the report, GRIP STRENGTH (Hard to pick up things), INJECTION SITE WARMTH (warm at the injection site), INJECTION SITE PRURITUS (itchy at the injection site), MYALGIA (muscle aches on the whole side of the arm), INJECTION SITE PAIN (sore at the injection site) and INJECTION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Hard to pick up things; warm at the injection site; itchy at the injection site; muscle aches on the whole side of the arm; sore at the injection site; red at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of GRIP STRENGTH (Hard to pick up things), INJECTION SITE WARMTH (warm at the injection site), INJECTION SITE PRURITUS (itchy at the injection site), MYALGIA (muscle aches on the whole side of the arm) and INJECTION SITE PAIN (sore at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced GRIP STRENGTH (Hard to pick up things), INJECTION SITE WARMTH (warm at the injection site), INJECTION SITE PRURITUS (itchy at the injection site), MYALGIA (muscle aches on the whole side of the arm), INJECTION SITE PAIN (sore at the injection site) and INJECTION SITE ERYTHEMA (red at the injection site). At the time of the report, GRIP STRENGTH (Hard to pick up things), INJECTION SITE WARMTH (warm at the injection site), INJECTION SITE PRURITUS (itchy at the injection site), MYALGIA (muscle aches on the whole side of the arm), INJECTION SITE PAIN (sore at the injection site) and INJECTION SITE ERYTHEMA (red at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Product dose omission issue
Clinical narrative: has been more than 6 weeks and he still has not received the second dose.; 17 year old patient received the vaccine; A spontaneous report was received from a nurse concerning a 17 year-old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and had been more than 6 weeks and he still had not received the second dose..  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, was not reported.  On 13 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot unknown) intramuscularly for prophylaxis of COVID-19 infection.   It had been more than 6 weeks and he still had not received the second dose.  Treatment for the events was not reported.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the events were considered recovered.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17-year-old) and product dose omission issue (second dose) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Groin pain, Lymph node pain, Lymphadenopathy, Peripheral swelling
Clinical narrative: Groin pain\ somewhat tender; Groin swelling\ groin area in the junction of my leg and torso on right side was swollen; Swelling arm; Unusal taste; Armpit pain; Itchy red circular rash where I received my shot; Vaccination site rash; Itchy red circular rash where I received my shot; lymph node swollen; swollen and sore to touch; This spontaneous case was reported by a consumer and describes the occurrence of GROIN PAIN (Groin pain\ somewhat tender), SWELLING (Groin swelling\ groin area in the junction of my leg and torso on right side was swollen), PERIPHERAL SWELLING (Swelling arm), TASTE DISORDER (Unusal taste) and AXILLARY PAIN (Armpit pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GROIN PAIN (Groin pain\ somewhat tender), SWELLING (Groin swelling\ groin area in the junction of my leg and torso on right side was swollen), PERIPHERAL SWELLING (Swelling arm), TASTE DISORDER (Unusal taste), AXILLARY PAIN (Armpit pain), VACCINATION SITE PRURITUS (Itchy red circular rash where I received my shot), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Itchy red circular rash where I received my shot), LYMPHADENOPATHY (lymph node swollen) and LYMPH NODE PAIN (swollen and sore to touch). At the time of the report, GROIN PAIN (Groin pain\ somewhat tender), SWELLING (Groin swelling\ groin area in the junction of my leg and torso on right side was swollen), PERIPHERAL SWELLING (Swelling arm), TASTE DISORDER (Unusal taste), AXILLARY PAIN (Armpit pain), VACCINATION SITE PRURITUS (Itchy red circular rash where I received my shot), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Itchy red circular rash where I received my shot), LYMPHADENOPATHY (lymph node swollen) and LYMPH NODE PAIN (swollen and sore to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not reported .  Concomitant medication were not reported .   This case was linked to MOD-2021-243638 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Contains no new information On 30-Jun-2021: targeted questionnaire
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Taste disorder, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Groin pain\ somewhat tender; Groin swelling\ groin area in the junction of my leg and torso on right side was swollen; Swelling arm; Unusal taste; Armpit pain; Itchy red circular rash where I received my shot; Vaccination site rash; Itchy red circular rash where I received my shot; lymph node swollen; swollen and sore to touch; This spontaneous case was reported by a consumer and describes the occurrence of GROIN PAIN (Groin pain\ somewhat tender), SWELLING (Groin swelling\ groin area in the junction of my leg and torso on right side was swollen), PERIPHERAL SWELLING (Swelling arm), TASTE DISORDER (Unusal taste) and AXILLARY PAIN (Armpit pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001L21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced GROIN PAIN (Groin pain\ somewhat tender), SWELLING (Groin swelling\ groin area in the junction of my leg and torso on right side was swollen), PERIPHERAL SWELLING (Swelling arm), TASTE DISORDER (Unusal taste), AXILLARY PAIN (Armpit pain), VACCINATION SITE PRURITUS (Itchy red circular rash where I received my shot), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Itchy red circular rash where I received my shot), LYMPHADENOPATHY (lymph node swollen) and LYMPH NODE PAIN (swollen and sore to touch). At the time of the report, GROIN PAIN (Groin pain\ somewhat tender), SWELLING (Groin swelling\ groin area in the junction of my leg and torso on right side was swollen), PERIPHERAL SWELLING (Swelling arm), TASTE DISORDER (Unusal taste), AXILLARY PAIN (Armpit pain), VACCINATION SITE PRURITUS (Itchy red circular rash where I received my shot), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Itchy red circular rash where I received my shot), LYMPHADENOPATHY (lymph node swollen) and LYMPH NODE PAIN (swollen and sore to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not reported .  Concomitant medication were not reported .   This case was linked to MOD-2021-243638 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: Contains no new information On 30-Jun-2021: targeted questionnaire
Sex: M
Vaccine: COVID19
Symptoms: Infection, Product dose omission issue
Clinical narrative: Infection; Missed my second dose because he was taking antibiotics; A spontaneous report was received from a consumer concerning himself, a male patient who experienced an infection causing him to miss his second dose of mRNA-1273 because he was taking antibiotics (product dose omission issue).  The patient's medical history was not provided. Concomitant product use was not provided/unknown.   On an unknown date, this patient received his first of two planned doses of mRNA-1273 (Lot/Batch number: Not provided) intramuscularly for prophylaxis of COVID-19 infection.   On 15-Mar-2021, the patient was scheduled for his second dose of the vaccine, but missed this dose because he was on antibiotics for an infection.  Treatment information was not provided/unknown.  Action taken with mRNA-1273 in response to the events was not provided/unknown.  The outcome for the events, infection and missed second dose because he was taking antibiotics, were not provided/unknown.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I missed my scheduled 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I missed my scheduled 2nd dose) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O12M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) mRNA-1273. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I missed my scheduled 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I missed my scheduled 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: No specific follow-up information recorded.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Little sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little sore arm) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PAIN (Little sore arm). At the time of the report, VACCINATION SITE PAIN (Little sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pain in extremity
Clinical narrative: a really bad headache; diarrhea; soreness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm), DIARRHOEA (diarrhea) and HEADACHE (a really bad headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESOMEPRAZOLE, CALCIUM, COLECALCIFEROL (VIT D3) and LEVOTHYROXINE for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (soreness in the arm). On 20-Feb-2021, the patient experienced DIARRHOEA (diarrhea). On 23-Feb-2021, the patient experienced HEADACHE (a really bad headache). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm and Headache, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness in the arm), DIARRHOEA (diarrhea) and HEADACHE (a really bad headache) outcome was unknown.            The treatment medication was Tylenol.  Action taken with mRNA-1273 in response to the events were not applicable.   This case was linked to MOD-2021-024497 (Patient Link).
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old patient inadvertently received their 1st Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient inadvertently received their 1st Moderna vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient inadvertently received their 1st Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient inadvertently received their 1st Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: 1st dose and tested positive for COVID afterwards; she already passed 42 days time frame; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (1st dose and tested positive for COVID afterwards) and PRODUCT DOSE OMISSION ISSUE (she already passed 42 days time frame) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (1st dose and tested positive for COVID afterwards) and PRODUCT DOSE OMISSION ISSUE (she already passed 42 days time frame). At the time of the report, SARS-COV-2 TEST POSITIVE (1st dose and tested positive for COVID afterwards) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: No specific follow-up information recorded.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vaccination site swelling
Clinical narrative: full body rash; swelling on injection arm; This spontaneous case was reported by a nurse and describes the occurrence of RASH (full body rash) and VACCINATION SITE SWELLING (swelling on injection arm) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, the patient experienced RASH (full body rash) and VACCINATION SITE SWELLING (swelling on injection arm). At the time of the report, RASH (full body rash) and VACCINATION SITE SWELLING (swelling on injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant patient got second dose of moderna; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant patient got second dose of moderna) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 21-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 21-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant patient got second dose of moderna). On 21-Mar-2021, EXPOSURE DURING PREGNANCY (Pregnant patient got second dose of moderna) had resolved.         Action taken with mRNA-1273 in response to the event was not applicable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Fatigue, Headache, Malaise
Clinical narrative: nauseous; dizzy; weak; General Malaise; vomited; tired; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (General Malaise), VOMITING (vomited) and FATIGUE (tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (General Malaise), VOMITING (vomited), FATIGUE (tired) and HEADACHE (bad headache). On 22-Mar-2021, the patient experienced NAUSEA (nauseous). At the time of the report, DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (General Malaise), VOMITING (vomited), FATIGUE (tired), HEADACHE (bad headache) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. The patient fell off the toilet.Patient still felt nauseous on 22-Mar-2021.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: nauseous; dizzy; weak; General Malaise; vomited; tired; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (General Malaise), VOMITING (vomited) and FATIGUE (tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (General Malaise), VOMITING (vomited), FATIGUE (tired) and HEADACHE (bad headache). On 22-Mar-2021, the patient experienced NAUSEA (nauseous). At the time of the report, DIZZINESS (dizzy), ASTHENIA (weak), MALAISE (General Malaise), VOMITING (vomited), FATIGUE (tired), HEADACHE (bad headache) and NAUSEA (nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. The patient fell off the toilet.Patient still felt nauseous on 22-Mar-2021.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DYSPNOEA (difficulty breathing). At the time of the report, DYSPNOEA (difficulty breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: aching in the body; aching in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aching in the body) and PAIN IN EXTREMITY (aching in the arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rhinitis.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (aching in the body) and PAIN IN EXTREMITY (aching in the arm). At the time of the report, PAIN (aching in the body) and PAIN IN EXTREMITY (aching in the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       As reported patient have rhinitis and normally use cetirizine. As reported patient wanted to know after getting the vaccine can they normally take their treatment.  Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dizziness, Feeling abnormal, Heavy menstrual bleeding, Menstrual disorder
Clinical narrative: Dizzy; Had period again/period deep dark red; Period not normal, very heavy, heavy clotting; Foggy; 50 cents painful; Purple bruise on L arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (50 cents painful), CONTUSION (Purple bruise on L arm of injection), MENSTRUAL DISORDER (Had period again/period deep dark red), HEAVY MENSTRUAL BLEEDING (Period not normal, very heavy, heavy clotting) and FEELING ABNORMAL (Foggy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder NOS (Immunosuppressed). Concomitant products included VITAMIN D [VITAMIN D NOS], HYDROXYCHLOROQUINE, PREGABALIN (LYRICA), TRAZODONE, CLONAZEPAM and METHOTREXATE for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (50 cents painful) and CONTUSION (Purple bruise on L arm of injection). On 19-Mar-2021, the patient experienced MENSTRUAL DISORDER (Had period again/period deep dark red), HEAVY MENSTRUAL BLEEDING (Period not normal, very heavy, heavy clotting) and FEELING ABNORMAL (Foggy). On an unknown date, the patient experienced DIZZINESS (Dizzy). On 21-Mar-2021, PAIN (50 cents painful) and CONTUSION (Purple bruise on L arm of injection) had resolved. At the time of the report, MENSTRUAL DISORDER (Had period again/period deep dark red), HEAVY MENSTRUAL BLEEDING (Period not normal, very heavy, heavy clotting), FEELING ABNORMAL (Foggy) and DIZZINESS (Dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Dizzy; Had period again/period deep dark red; Period not normal, very heavy, heavy clotting; Foggy; 50 cents painful; Purple bruise on L arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (50 cents painful), CONTUSION (Purple bruise on L arm of injection), MENSTRUAL DISORDER (Had period again/period deep dark red), HEAVY MENSTRUAL BLEEDING (Period not normal, very heavy, heavy clotting) and FEELING ABNORMAL (Foggy) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Autoimmune disorder NOS (Immunosuppressed). Concomitant products included VITAMIN D [VITAMIN D NOS], HYDROXYCHLOROQUINE, PREGABALIN (LYRICA), TRAZODONE, CLONAZEPAM and METHOTREXATE for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PAIN (50 cents painful) and CONTUSION (Purple bruise on L arm of injection). On 19-Mar-2021, the patient experienced MENSTRUAL DISORDER (Had period again/period deep dark red), HEAVY MENSTRUAL BLEEDING (Period not normal, very heavy, heavy clotting) and FEELING ABNORMAL (Foggy). On an unknown date, the patient experienced DIZZINESS (Dizzy). On 21-Mar-2021, PAIN (50 cents painful) and CONTUSION (Purple bruise on L arm of injection) had resolved. At the time of the report, MENSTRUAL DISORDER (Had period again/period deep dark red), HEAVY MENSTRUAL BLEEDING (Period not normal, very heavy, heavy clotting), FEELING ABNORMAL (Foggy) and DIZZINESS (Dizzy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Paraesthesia, Product dose omission issue, Swollen tongue
Clinical narrative: tingling; swelling of the lips and tongue; swelling of the lips and tongue; vaccine provider refused to administer her with the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling), LIP SWELLING (swelling of the lips and tongue), SWOLLEN TONGUE (swelling of the lips and tongue) and PRODUCT DOSE OMISSION ISSUE (vaccine provider refused to administer her with the 2nd dose) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling), LIP SWELLING (swelling of the lips and tongue), SWOLLEN TONGUE (swelling of the lips and tongue) and PRODUCT DOSE OMISSION ISSUE (vaccine provider refused to administer her with the 2nd dose). At the time of the report, PARAESTHESIA (tingling), LIP SWELLING (swelling of the lips and tongue), SWOLLEN TONGUE (swelling of the lips and tongue) and PRODUCT DOSE OMISSION ISSUE (vaccine provider refused to administer her with the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Type 1 diabetes mellitus. Concomitant products included INSULIN ASPART (NOVOLOG), LISINOPRIL, HYDROCHLOORTHIAZIDE, BUPROPION, LEVOTHYROXINE, ROSUVASTATIN, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, DIARRHOEA (diarrhea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Mobility decreased, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: No appetite; felt draggy; ached all over; fever off & on; mild pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (No appetite), MOBILITY DECREASED (felt draggy), MYALGIA (ached all over), PYREXIA (fever off & on) and VACCINATION SITE PAIN (mild pain at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced DECREASED APPETITE (No appetite), MOBILITY DECREASED (felt draggy), MYALGIA (ached all over), PYREXIA (fever off & on) and VACCINATION SITE PAIN (mild pain at the injection site). At the time of the report, DECREASED APPETITE (No appetite), MOBILITY DECREASED (felt draggy), MYALGIA (ached all over), PYREXIA (fever off & on) and VACCINATION SITE PAIN (mild pain at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Pain in extremity
Clinical narrative: chest pain near the shoulder; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and CHEST PAIN (chest pain near the shoulder) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 immunisation.     The patient's past medical history included No adverse event.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 21-Mar-2021, the patient experienced CHEST PAIN (chest pain near the shoulder). At the time of the report, PAIN IN EXTREMITY (arm pain) and CHEST PAIN (chest pain near the shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.